Royalty Pharma plc (RPRX) on GreekSoup https://greeksoup.ai/stocks/us/rprx/ Every dated entry in the public record on Royalty Pharma plc: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Royalty Pharma plc: short interest 12,843,101 shares at the 15 October 2026 settlement, 4.28 days to coverhttps://greeksoup.ai/stocks/us/rprx/short-interest/us:RPRX:short-interest:2026-10-15:51db29d35fThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Form 144, Urist Marshall plans to sell 4,126 shares worth $235,595 around 5 October 2026https://greeksoup.ai/stocks/us/rprx/planned-sales/us:RPRX:planned-sale:2026-10-05:4f166c598aMon, 05 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Urist Marshall (EVP, Research & Investments) sold 4,126 shares (under a trading plan set in advance) at $57.10 on 5 October 2026, $235,595https://greeksoup.ai/stocks/us/rprx/insiders/us:RPRX:insider:2026-10-05:3120bfe13cMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Bassler Bonnie L (Director) took 642 shares in place of pay owed in cash (company plan, the filing does not say it was a choice) on 30 September 2026https://greeksoup.ai/stocks/us/rprx/insiders/us:RPRX:insider:2026-09-30:7255a648d8Wed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Urist Marshall (EVP, Research & Investments) sold 4,126 shares (under a trading plan set in advance) at $57.88 on 28 September 2026, $238,813https://greeksoup.ai/stocks/us/rprx/insiders/us:RPRX:insider:2026-09-30:71d1748b6bWed, 30 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: short interest 12,885,147 shares at the 30 September 2026 settlement, 4.44 days to coverhttps://greeksoup.ai/stocks/us/rprx/short-interest/us:RPRX:short-interest:2026-09-30:fa116d489bWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Form 144, Urist Marshall plans to sell 4,126 shares worth $238,813 around 28 September 2026https://greeksoup.ai/stocks/us/rprx/planned-sales/us:RPRX:planned-sale:2026-09-28:25bb69acbcMon, 28 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Hite Christopher (EVP & Chairman, Partnering), by SCH Investment Partners LLC, sold 96,073 shares (under a trading plan set in advance) at $58.51 on 22 September 2026, $5.6 millionhttps://greeksoup.ai/stocks/us/rprx/insiders/us:RPRX:insider:2026-09-24:a74601fe92Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Hite Christopher (EVP & Chairman, Partnering), by SCH Investment Partners LLC, sold 3,927 shares (under a trading plan set in advance) at $58.93 on 22 September 2026, $231,403https://greeksoup.ai/stocks/us/rprx/insiders/us:RPRX:insider:2026-09-24:877afcddb6Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Form 144, SCH Investment Partners LLC plans to sell 100,000 shares worth $5.8 million around 22 September 2026https://greeksoup.ai/stocks/us/rprx/planned-sales/us:RPRX:planned-sale:2026-09-22:a34d039a9aTue, 22 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: short interest 11,647,565 shares at the 15 September 2026 settlement, 3.25 days to coverhttps://greeksoup.ai/stocks/us/rprx/short-interest/us:RPRX:short-interest:2026-09-15:a0addc57bbTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: short interest 11,903,716 shares at the 31 August 2026 settlement, 5.05 days to coverhttps://greeksoup.ai/stocks/us/rprx/short-interest/us:RPRX:short-interest:2026-08-31:864a1f2fd2Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Hite Christopher (EVP & Chairman, Partnering), by SCH Investment Partners LLC, sold 100,000 shares (under a trading plan set in advance) at $59.97 on 18 August 2026, $6.0 millionhttps://greeksoup.ai/stocks/us/rprx/insiders/us:RPRX:insider:2026-08-19:1c68391eb6Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Form 144, SCH Investment Partners LLC plans to sell 100,000 shares worth $6.0 million around 18 August 2026https://greeksoup.ai/stocks/us/rprx/planned-sales/us:RPRX:planned-sale:2026-08-18:5e2915f51aTue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Schedule 13D/A filed by Legorreta G. Pablo, 18.7% of the classhttps://greeksoup.ai/stocks/us/rprx/holders/us:RPRX:schedule-13:2026-08-17:09adde9881Mon, 17 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Coyne Terrance P. (EVP & CFO), tPC RP EPA1 LLC, sold 9,230 shares (under a trading plan set in advance) at $58.59 on 13 August 2026, $540,752https://greeksoup.ai/stocks/us/rprx/insiders/us:RPRX:insider:2026-08-17:2fc4395795Mon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Coyne Terrance P. (EVP & CFO), tPC RP EPA1 LLC, sold 1,772 shares (under a trading plan set in advance) at $59.14 on 13 August 2026, $104,799https://greeksoup.ai/stocks/us/rprx/insiders/us:RPRX:insider:2026-08-17:17542f58aeMon, 17 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: short interest 11,606,728 shares at the 14 August 2026 settlement, 3.77 days to coverhttps://greeksoup.ai/stocks/us/rprx/short-interest/us:RPRX:short-interest:2026-08-14:c95b7e219aFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Form 144, Terrance Coyne plans to sell 11,002 shares worth $644,277 around 13 August 2026https://greeksoup.ai/stocks/us/rprx/planned-sales/us:RPRX:planned-sale:2026-08-13:533c45fb45Thu, 13 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Form 144, Errol B. De Souza plans to sell 125,000 shares worth $7.2 million around 12 August 2026https://greeksoup.ai/stocks/us/rprx/planned-sales/us:RPRX:planned-sale:2026-08-12:be36b4bee5Wed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: Form 144, Errol B. De Souza plans to sell 206,352 shares worth $11.9 million around 12 August 2026https://greeksoup.ai/stocks/us/rprx/planned-sales/us:RPRX:planned-sale:2026-08-12:e656321dbbWed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Royalty Pharma plc Q2 FY2026 results: revenue $674 million, net income $18 millionhttps://greeksoup.ai/stocks/us/rprx/results/fy2026-q2/us:RPRX:result:2026-08-05:efd247a98fWed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Royalty Pharma plc filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/rprx/filings/us:RPRX:filing:2026-08-05:54c60038a7Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Royalty Pharma plc filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/rprx/filings/us:RPRX:filing:2026-08-05:e3429c2baeWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Royalty Pharma plc: short interest 10,667,818 shares at the 31 July 2026 settlement, 4.07 days to coverhttps://greeksoup.ai/stocks/us/rprx/short-interest/us:RPRX:short-interest:2026-07-31:cbdfa404f4Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>